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demonstrated high-level resistance to both drugs. Because none of the patients from which the isolates were recovered had been treated with any of the drugs in question, no explanation was possible as to how resistance emerged in these strains. This prompted our group to undertake a pilot survey of specially selected sites on the Chesapeake Bay and upper watershed in an effort to determine the type and scope of antimicrobial resistance present in these waters.
In the summer of 2012, we recovered a strain of Mycobacterium cosmeticum, a rapid-growing (RG) mycobacterial species, which was first described in 2004. [6] [7] [8] Initially isolated from a patient undergoing a cosmetic procedure, M. cosmeticum has subsequently been associated with an outbreak in a nail salon. [6] [7] [8] The exact environmental niche for M. cosmeticum has not been definitively identified. However, it is thought to exist in a water-based habitat and the M. cosmeticum strains recovered initially were susceptible to most antibiotics tested.
In this study, we describe the isolation of a strain of M. cosmeticum from water samples obtained from the Chesapeake Bay resistant to a number of antibiotics, including doxycycline. Recovery of this drug-resistant isolate raises important questions regarding antibiotic use and disposal not only in human medicine but also in agriculture.
MaterIals and Methods
A pilot survey of the Chesapeake Bay and upper tributaries was conducted in July 2012 to assess bacterial diversity and antimicrobial resistance. Ten locations were selected based on sites previously sampled in 1976 to be used as a comparative reference and those with current proximity to industrial agriculture, human habitation, and sewage runoff. [9] Two sampling sites per location were chosen and global positioning system (GPS) coordinates were recorded for each site [ Table 1 ]. For Chesapeake Bay sites, sampling was done proximal to the shore (within several yards) as well as further out at a range from 137.16 m (150 yards) to 274.32 m (300 yards). Sampling for the upper watershed sites, consisting of rivers and creeks, was done close to the bank, where little current was visible, and further out, where the flow was most rapid. Personnel collecting and processing surface water samples wore gloves to avoid contamination of samples by normal skin flora. Aliquots (500 mL) were collected in sterile, glass, screw-capped bottles that were not opened until they were submerged in the water. All samples were chilled on ice and subsequently transported back to the laboratory for processing. Water samples were poured through glass filtration units containing presterilized 0.2-µm bacterial recovery filters (Millipore, Billerica, MA, USA). For recovery of mycobacteria, filters were subsequently placed in Middlebrook 7H9 (M7H9) broth containing a commercially available mixture of antibiotics (PANTA: nalidixic acid, polymyxin B, amphotericin B, trimethoprim/sulfamethoxazole, and azlocillin; Becton Dickinson, Sparks, MD, USA). Samples were incubated at 30°C and 37°C for up to 6 weeks to permit recovery of mycobacteria. All broth tubes were visually examined daily for detection of growth. Positive broth cultures were plated on Middlebrook 7H10 (M7H10) agar to obtain isolated colonies. Ziehl-Neelsen staining was used to identify acid-fast bacilli, which were subsequently identified to the species level using 16S ribosomal DNA (rDNA) sequencing.
Following species-level identification, antimicrobialsusceptibility testing (AST) was performed using a commercially available microbroth dilution assay (Sensititre, Thermo Scientific, TREK Diagnostic Systems, Cleveland, OH, USA), and the minimum inhibitory concentration (MIC) was determined for each antimicrobial agent. The following antimicrobial agents were tested: imipenem, cefoxitin, amikacin, tobramycin, doxycycline, ciprofloxacin, clarithromycin, linezolid, trimethoprim/sulfamethoxazole, tigecycline, rifabutin, rifampin, ethambutol, and ethionamide. In brief, isolate suspensions were prepared using fresh growth samples from M7H10 agar, which was added to a test tube containing 10-20 sterile beads submerged in 5 mL of Müller-Hinton (MH) broth (TREK Diagnostic Systems). Suspensions were thoroughly vortexed and subsequently allowed to settle for 5-10 min. The supernatant was then adjusted to a 0.5 McFarland standard and further diluted (50 µL in 11-mL MH broth) to obtain a target inoculum of 5 × 10 5 colony-forming unit (CFU)/mL to 1 × 10 6 CFU/mL, Table 2 ]. These MICs were then compared with those reported for the original type strains, first described in 2004, which were isolated from a female patient in Venezuela and a hair salon in Ohio. [6, 7] As shown in Table 2 Interestingly, no mycobacteria were recovered from any of the other geographic sites that were sampled in this study.
dIscussIon
To date, M. cosmeticum isolates obtained from various clinical and other sources were reported to be susceptible to most antimicrobial agents with little to no evidence of resistance. In this work, we report antimicrobial-susceptibility data for an M. cosmeticum isolate recovered from the waters off Sandy Point State Park (Chesapeake Bay, Maryland, USA), with resistance to most of the antimicrobial agents commonly used for AST for such isolates, including imipenem, cefoxitin, doxycycline, tobramycin, trimethoprim/sulfamethoxazole, and tigecycline. Such resistance in M. cosmeticum is highly unusual based on published data; [6] [7] [8] however, unexplained antimicrobial resistance is not without precedent in bacterial isolates recovered from the Chesapeake Bay. Previously, we published a case of an unexplained antibiotic resistance that was observed in another mycobacterial species, M. marinum, isolated from a patient who suffered a fish hook injury while engaging in recreational activities on the eastern shore of the Chesapeake Bay. [5] As with the M. cosmeticum recovered in this study, this particular M. marinum strain demonstrated resistance to doxycycline and rifampin, an unusual finding for this species. [5] Like M. cosmeticum, M. marinum is generally considered to be susceptible to most antimicrobial agents. For that reason, AST is not routinely recommended and/or performed for this species. In addition, intrinsic or acquired resistance, especially to rifampin, has not been reported for M. marinum and the patient in this case had never been exposed to rifampin or any other rifamycins as part of a treatment regimen. [5] Thus, selective pressure in the conventional sense (i.e., exposure of a bacterium in vivo to a drug) is unlikely to have been the cause of resistance. Instead, it was suggested that this particular M. marinum strain may have acquired resistance through antibiotic exposure in the natural environment. [5] In this report of M. cosmeticum, it is not known if the resistance was due to exposure of the organism to antibiotics in the natural environment. Previous M. cosmeticum strains, all of which had been recovered from infected patients, were susceptible to most antimicrobial agents tested. [6] [7] [8] Presumably, all of these cases were due to environmental exposure, primarily through water containing these organisms (e.g., medical devices, foot baths). [6] [7] [8] Although it was previously proposed that M. cosmeticum may exist in environmental reservoirs, no definitive evidence to support this concept has been found. [6] [7] [8] To the best of our knowledge, this is the first report of M. cosmeticum being isolated directly from a natural environment. Most NTM isolates are ubiquitous in the environment and inhabit a variety of ecological niches, including soil and water (marshland, streams, rivers, and estuaries). It is entirely possible that this body of water and associated drainage area represent typical habitat for the M. cosmeticum species. Sandy Point State Park, Annapolis, Maryland, is located on a peninsula on the northwestern shore of the Chesapeake Bay, in proximity to the Chesapeake Bay Bridge. This particular body of water is openly connected to the Chesapeake Bay; the beach area along the shore is used for recreational human activities, especially in the summer months. Thus, it is also possible that this M. cosmeticum strain may be a human isolate transferred to the watershed.
Determination of the origin of the M. cosmeticum strain recovered in this study and the specific molecular determinants of resistance were beyond the scope of this project. Nonetheless, as with the M. marinum strain described in a prior study, [5] the observed antibiotic resistance raises some interesting questions. Antimicrobial resistance in mycobacteria is thought to be primarily due to chromosomal mutations, which arise from exposure of the organism to a particular drug. This exposure can occur in vivo during treatment or alternatively in the environment should a particular antibiotic be present in sufficient concentration. The M. cosmeticum strain recovered in this study was not only resistant to some standard antimicrobial agents used for treatment of NTM infections (clarithromycin, tobramycin, doxycycline, and tigecycline) but also resistant to other agents used for the treatment of tuberculosis (rifampin and ethionamide). In the latter case, it is possible that resistance to tuberculosis-specific drugs may be inherent in this species as has been observed with other NTM, especially the RG-NTM such as Mycobacterium abscessus, Mycobacterium fortuitum, and Mycobacterium chelonae. [11, 12] Intrinsic resistance may also play a role with respect to doxycycline. It is well documented that tetracycline (e.g., doxycycline and minocycline) resistance has limited the use of this class of drugs for the treatment of many NTM infections. However, given that the clinical strains of this species recovered to date were susceptible to this drug, this seems less likely.
Perhaps, most puzzling of the susceptibility results obtained in this study was the resistance of this M. cosmeticum strain to tigecycline (MIC ≥4 μg/mL). Tigecycline, a glycylcycline, is not as heavily used therapeutically, and thus, resistance of NTM to tigecycline has not been as widespread when compared with other antibiotics. Glycylcyclines are second-generation tetracyclines that are considered superior to tetracyclines because they are generally unaffected by common tetracycline-resistance mechanisms such as efflux pumps and ribosomal protection. [13, 14] To date, tigecycline has shown strong activity against most RG-NTM species tested, including tetracycline-resistant strain. [15, 16] Because M. cosmeticum is an RG-NTM, the relatively high MIC to tigecycline was unexpected and at this time unexplained. Evidence is emerging supporting horizontal gene transfer between mycobacterial species as well as between mycobacteria and other bacteria occupying the same microenvironment. [17] Further investigations are needed to confirm this possibility with respect to the M. cosmeticum recovered from the waters off Sandy Point State Park.
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